A newly approved pill form of GLP-1 medication could revolutionize obesity treatment by offering a convenient alternative to ...
WASHINGTON (AP) — Food and Drug Administration regulators on Tuesday approved a first-of-a-kind drug for a rare form of Lou Gehrig’s disease, though they are requiring further research to confirm it ...
Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...
DURHAM, N.C. (WTVD) -- A popular weight loss drug made in the Triangle is now available in pill form. On Monday, pharmaceutical company Novo Nordisk announced FDA approval of a new Wegovy pill, the ...
Am J Health Syst Pharm. 2006;63(11):1022-1028. Q: How can potential medication errors be minimized when dispensing investigational drugs to better ensure patient safety and improve adherence to the ...
Eli Lilly (the company behind Mounjaro and Zepbound) just announced impressive phase 3 clinical trial results for a new weight loss medication, orforglipron, a GLP-1. Orforglipron is an oral ...
(CNN) — The US Food and Drug Administration has approved the first medication for a common form of liver inflammation called nonalcoholic steatohepatitis, or NASH, the agency said Thursday. NASH — ...
A medication that’s been making news for strong results in terms of weight loss is now available in the U.S. in pill form. Novo Nordisk announced Monday that its popular semaglutide drug Wegovy is the ...
Add Yahoo as a preferred source to see more of our stories on Google. A new drug is transforming the lives of children born with a severe form of epilepsy, say doctors and families. Dravet syndrome ...